You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cisplatin-pemetrexed

Showing 1 - 25 of 3,214
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-squamous Non-small-cell Lung Cancer Trial in Hangzhou (Tusamitamab ravtansine+Sintilimab+Carboplatin or

Not yet recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • Tusamitamab ravtansine+Sintilimab+Carboplatin or Cisplatin+Pemetrexed
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
May 5, 2023

NSCLC Trial in Xi'an (Furmonertinib+cisplating/pemetrexed)

Recruiting
  • Non-small Cell Lung Cancer
  • Xi'an, Shannxi, China
    Tangdu Hospital
Jun 20, 2022

Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,

Active, not recruiting
  • Non-Squamous Non-Small Cell Lung Carcinoma
  • +7 more
  • Nivolumab
  • +3 more
  • Abington, Pennsylvania
  • +1 more
Sep 14, 2022

Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)

Not yet recruiting
  • Pleural Mesothelioma
  • Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
  • Rozzano, MI, Italy
  • +5 more
Nov 30, 2023

PFS, OS Trial in Qingdao (PD-1 inhibitor, Bevacizumab, Carboplatin, Cisplatin, Pemtrexed)

Recruiting
  • PFS
  • OS
  • PD-1 inhibitor, Bevacizumab, Carboplatin, Cisplatin, Pemtrexed
  • Qingdao, Shandong, China
    Qingdao central Hospital
Feb 23, 2022

Sarcoma Trial in Seoul (Pemetrexed, cisplatin)

Active, not recruiting
  • Sarcoma
  • Pemetrexed, cisplatin
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
May 30, 2022

Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)

Recruiting
  • Lung Cancer
  • AMG 510
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

Nonsquamous Nonsmall Cell Tumor of Lung Trial in Taipei (BLEX 404)

Not yet recruiting
  • Nonsquamous Nonsmall Cell Neoplasm of Lung
  • BLEX 404
  • Taipei, Taiwan
    Taipei Veteran General Hospital
Feb 28, 2023

Mesothelioma Trial in Houston (Pemetrexed, Cisplatin)

Terminated
  • Mesothelioma
  • Houston, Texas
    Baylor St Lukes
Mar 15, 2022

NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • (no location specified)
Jan 18, 2023

Non-Squamous NSCLC Trial in Shanghai (Sintilimab, IBI305, Pemetrexed)

Recruiting
  • Non-Squamous Non-Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Sep 22, 2022

Combining Genomics and Imageomics to Predict Sensitivity of

Not yet recruiting
  • Sensitivity
  • Neoadjuvant pemetrexed and cisplatin chemotherapy
  • (no location specified)
Jan 5, 2022

Carcinoma,Non-Small-Cell Lung Trial in Guangzhou (cisplatin and pemetrexed, nedaplatin+pemetrexed)

Recruiting
  • Carcinoma，Non-Small-Cell Lung
  • Guangzhou, Guangdong, China
    Sun Yat-sen University of cancer center
Feb 8, 2022

Carcinoma, Non-Small Cell Lung Trial in Netherlands (carboplatin, paclitaxel, Bevacizumab)

Active, not recruiting
  • Carcinoma, Non-Small Cell Lung
  • Amsterdam, Noord-Holland, Netherlands
  • +27 more
Dec 6, 2021

Non-Small-Cell Lung Carcinoma Trial (biological, drug, dietary supplement)

Active, not recruiting
Has Results
  • Non-Small-Cell Lung Carcinoma
  • Pembrolizumab 200 mg
  • +7 more
  • (no location specified)
Aug 16, 2022

NSCLC Trial (SKB264, Pemetrexed, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
May 23, 2023

Adenocarcinoma of Lung, Lung Cancer Trial in Minneapolis (Oral Restorative Microbiota Therapy (RMT) Capsules, Durvalumab 1500 mg

Not yet recruiting
  • Adenocarcinoma of Lung
  • Lung Cancer
  • Oral Restorative Microbiota Therapy (RMT) Capsules
  • +3 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Apr 4, 2022

MPM Trial in Changchun (PM8002, Pemetrexed, Cisplatin)

Recruiting
  • MPM
  • Changchun, China
    Jilin Provincial Tumor Hospital
Jun 25, 2023

NSCLC Trial in Canada, United States (Nivolumab, Gemcitabine, Cisplatin)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Nivolumab
  • +8 more
  • Los Angeles, California
  • +11 more
Sep 20, 2021

NSCLC Trial (HS-10241+ Almonertinib, Pemetrexed + Cisplatin /Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • HS-10241+ Almonertinib
  • Pemetrexed + Cisplatin /Carboplatin
  • (no location specified)
Oct 29, 2023

Mesothelioma Trial in Durham, Houston (Durvalumab / tremelimumab, Platinum cisplatin or carboplatin and pemetrexed chemo plus

Not yet recruiting
  • Mesothelioma
  • Durvalumab / tremelimumab
  • Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab
  • Durham, North Carolina
  • +1 more
Jul 5, 2023

Solid Tumor, Adult, Non-Hodgkin Lymphoma, Adult, NSCLC Trial in Rozzano, Siena, Glasgow (IOA-244, Avelumab Injection,

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • Rozzano, Milan, Italy
  • +2 more
May 13, 2022

Lung Cancer, Non-squamous, Non-small Cell Trial (zongertinib, pembrolizumab, cisplatin)

Not yet recruiting
  • Lung Cancer, Non-squamous, Non-small Cell
  • (no location specified)
Nov 22, 2023

Non Small Cell Lung Cancer Trial in Worldwide (IPH5201 + durvalumab + standard chemo)

Recruiting
  • Non Small Cell Lung Cancer
  • IPH5201 + durvalumab + standard chemotherapy
  • Tampa, Florida
  • +23 more
Feb 23, 2023

Non-Small-Cell Lung Carcinoma Trial in Japan (biological, drug, dietary supplement)

Active, not recruiting
Has Results
  • Non-Small-Cell Lung Carcinoma
  • Pembrolizumab 200 mg
  • +7 more
  • Nagoya, Aichi, Japan
  • +9 more
Jan 23, 2023